baber/WOPTO huggingface dataset:
Patent NZ-576152-A (NZ)
Title: A sterilizer where the temperature of the water is monitored and drained out if it exceeds a set temperature
Inventor: BRAGULLA GEORGE REINER
IPC: C02F1/32
Filed: 2009-04-09
Abstract: A UV steriliser (1) is disclosed. The steriliser (1) has a housing (2) containing an ultra violet lamp (17) within a fluid pathway. First (3) and second (5) conduits in fluid communication with the housing (2) connect the housing to a reservoir and an end-use respectively. If water stops flowing for a length of time, its temperature will rise due to the radiation from the UV lamp (17). If the temperature is allowed to get too high it may damage the UV lamp (17) or pose a risk of scalding to a user. It is also disclosed the sterilisation of water using UV radiation loses efficiency when the temperature of the water exceeds 42 Co. To prevent these occurrences, the sterilizer includes a release valve (19) to release fluid from the fluid pathway if the temperature of the water exceeds a predetermined threshold, as determined by a trigger (20).
Patent NZ-576428-A (NZ)
Title: Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
Inventor: PALUCKA ANNA KAROLINA
IPC: G16B25/10
Filed: 2007-11-03
Abstract: Provided is a method of identifying a subject with melanoma comprising: determining a level of expression of one or more melanoma expression vectors in a previously obtained sample, wherein a level of expression is determined using at least one technique selected from the group consisting of polymerase chain reaction, heteroduplex analysis, single stand conformational polymorphism analysis, ligase chain reaction, comparative genome hybridization, southern blotting, northern blotting, western blotting, enzyme-linked immunosorbent assay, fluorescent resonance energy-transfer and sequencing; and displaying each of the melanoma expression vectors with a separate identifier, wherein the one or more melanoma expression vectors comprise three or more genes. Further provided are corresponding microarrays for diagnosis.
Patent NZ-580371-A (NZ)
Title: Highly stable electrolytic water with reduced nmr half line width
Inventor: CHEN YONGGE
IPC: C25B9/19
Filed: 2008-04-25
Abstract: Disclosed is an electrolytic acid water having (a) a NMR half line width using 17O of from about 45 to less than 50 Hz; (b) an oxide reduction potential of from +900 to +1250 mV; (c) a pH of from 0.5 to 5.0; (d) from 40 to 70 mg/l of free chlorine measured spectrophotometrically; (e) from 40 to 70 mg/l of total chlorine measured spectrophotometrically; (f) from 40 to 70 mg/l of total chlorine measured iodometrically; (g) less than 10 mg/l chlorates; and (h) less than 10 ppm heavy metals, including less than 5 ìg/l of cadmium, less than 10 ìg/l of chromium, less than 5 ìg/l of lead, and less than 20 ìg/l of nickel; characterized by chemical stability for greater than 180 days when protected from light, air and heat, wherein said chemical stability is defined by no greater than a 10 percent variation in pH or NMR half line width during said 180 days. Also disclosed is the use of the water in the manufacture of a medicament or cosmetic composition for treating fungal infections, a method of making the water and the unit used for making the waste which comprises a cathode chamber comprising a cathode, an anode chamber comprising an anode, and a nanoporous filter separating said chambers, wherein: c) said cathode and said anode are coated by a residue of nano-particles in which greater than 70 per cent by weight of said particles have a diameter of from 40 to 100 nm; and d) said nano-porous filter comprises a mean pore size of from 120 to 180 nanometers.
Patent NZ-583019-A (NZ)
Title: Human antibodies to human cd20 and method of using thereof
Inventor: MARTIN JOEL H
IPC: A61K39/395
Filed: 2008-07-31
Abstract: Disclosed is a human antibody or antigen-binding fragment of an antibody that specifically binds human CD20 and is capable of inducing complement dependent cytotoxicity (CDC) in a human lymphoma cell line with an antibody concentration of about 5 nM or less, and increasing symptom free survival time about 9-fold or more, relative to human Fc control-treated animals in a mouse model of human lymphoma. Also disclosed are nucleic acid molecules encoding the antibody, expression vectors and pharmaceutical compositions.
Patent NZ-583396-A (NZ)
Title: Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
Inventor: GAHLER ROLAND J
IPC: A23L29/256
Filed: 2008-07-29
Abstract: Disclosed herein is a dietary composition comprising a fiber composition comprising from about 48% to about 90% (w/w) glucomannan, from about 5% to about 20% (w/w) xanthan gum, and from about 5% to about 30% (w/w) alginate, and at least one lipid or blend thereof, wherein the fiber composition and the lipid or blend thereof are present in the dietary composition at a ratio of from about 50:50 (w/w fiber composition to lipid or blend thereof) to about 60:40 (w/w fiber composition to lipid or blend thereof), and wherein the dietary composition has a viscosity in water of from about 1 to about 3,500 centipoises after 5 minutes, and at least about 90,000 centipoises within 5 minutes under gastric conditions. Also disclosed is a method of producing a dietary comprising the steps of: (a) mixing from about 48% to about 90% (w/w) glucomannan, from about 5% to about 20% (w/w) xanthan gum, and from about 5% to about 30% (w/w) alginate to form a fiber composition; and (b) adding an amount of a lipid or blend thereof to an amount of the fiber composition of step (a) such that the fiber composition and the lipid or blend thereof are present in the dietary composition at a ratio of from about 50:50 (w/w fiber composition to lipid or blend thereof) to about 60:40 (w/w fiber composition to lipid or blend thereof); and (c) mixing to generate the dietary composition.
Patent NZ-586825-A (NZ)
Title: Aquatic algae cultivation system as floating structure open to sunlight, wind and waves
Inventor: BUSSELL STUART
IPC: C12M1/00
Filed: 2009-01-23
Abstract: Floating ponds for the cultivation of algae are disclosed. The floating ponds consist of a buoyant framework, a liner, a culture, and a mooring system. Submersible floating ponds are disclosed with a buoyant framework built from tubes that may be filled or partially filled with, for example, air, or water, or the surrounding water, or the culture, and thereby the present invention provides a framework in which the buoyancy may be modulated. Use of submerging lines and spools are disclosed to control the orientation and depth of the floating pond during submersion.
Patent NZ-591623-A (NZ)
Title: A method for a payment cardholder to control and manage the use of a payment card
Inventor: KEENAN ROB A
IPC: G06Q20/00
Filed: 2009-09-08
Abstract: 591623 Disclosed is a method for providing a payment cardholder (12) with control over a payment card (14). a set of usage parameters are configured, through the use of a managing platform (10), for usage of the payment card (14) The managing platform (10) then associates, via a processing device of the managing platform (10), the payment card (14) with the managing platform (10). The payment cardholder (12) is allowed, via an interface (16) of the managing platform (10), to select one or more of the usage parameters. A set of cardholder parameters are associated, by the processing device, with the payment card (14) based on the selected usage parameters. The cardholder parameters include defining rules for each the selected usage parameter for determining an acceptable transaction and an unacceptable transaction for the payment card (14). Authorizations are intercepted, by the processing device, for transactions of the payment card (14) transmitted by a merchant (30) to an issuer (18) of the payment card (14). Based on the cardholder parameters, each attempted transaction of the payment card is identified, by the processing device, as being one of the acceptable transactions or the unacceptable transactions. The managing platform (10) is an entity separate and distinct from both the issuer (18) and the merchant (30)
Patent NZ-597495-A (NZ)
Title: 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof
Inventor: DEGUCHI HIROSHI
IPC: A61K31/455
Filed: 2010-07-16
Abstract: Disclosed is Benzenesulfonate of 2- [[[2 - [(hydroxyacety1) amino]- 4 -pyridinyJ] methyl] thio]- N -[4 -(trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide and methods of producing the compound.
Patent NZ-599888-A (NZ)
Title: Tunably crosslinked hyaluronic acid compositions
Inventor: TEZEL AHMET
IPC: A61L27/20
Filed: 2008-07-24
Abstract: ABSTRACT - 599888 Disclosed herein is a process for preparing a degradation resistant crosslinked hyaluronic acid hydrogel, said process comprising: (a) hydrating sodium hyaluronate fibers in a sodium hydroxide solution to produce hydrated sodium hyaluronate fibers; (b) mixing the sodium hyaluronate fibers with a tetrafunctional polyethylene glycol-based epoxide crosslinking agent to create a sodium hyaluronate fiber mixture; (c) heating the sodium hyaluronate fiber mixture at a temperature between 40 °C to 70 °C for a time period of between 1 to 10 hours to produce a crosslinked hyaluronic acid hydrogel; (d) reacting the crosslinked hyaluronic acid hydrogel with a polyethylene glycol-based pendant; wherein the polyethylene glycol-based pendant coating provides degradation resistance to the crosslinked hyaluronic acid hydrogel, thereby enhancing in vivo longevity of the crosslinked hyaluronic acid hydrogel, and wherein the process uses the tetrafunctional polyethylene glycol-based epoxide crosslinking agent on its own for preparing the degradation resistant crosslinked hyaluronic acid hydrogel..
Patent NZ-600027-A (NZ)
Title: Improved method and machine for preparing espresso coffee
Inventor: BIANCHI ROBERTO
IPC: A47J31/36
Filed: 2010-10-25
Abstract: 600027 An espresso coffee machine is disclosed. The coffee machine comprises one or more operating units (10), wherein each of the one or more operating units comprises a boiler, a variable speed DC motor pump (13), a heating unit, a brewing group (26) for aroma extraction and dispensing of an espresso coffee brew, and conduits connecting the variable speed DC motor pump and the boiler to the brewing group. Each of the one or more operating units is equipped with a system for controlling and adjusting the espresso coffee brewing parameters. Each of the one or more operating units comprises a manual actuating means (16), comprising a rheostat (15), for adjusting water outlet pressure during coffee brewing. This allows the user to optimise the brewing parameters according to different coffee blends. A method for preparing espresso coffee is also disclosed.
Patent NZ-602118-A (NZ)
Title: Method and apparatus for cartridge-based carbonation of beverages
Inventor: PETERSON PETER
IPC: B01F3/04
Filed: 2011-01-31
Abstract: 602118 Disclosed is a beverage making system (1) and a method for forming a beverage. The beverage making system (1) comprises a precursor liquid supply (10); a cartridge chamber (3); a cartridge (4); a carbon dioxide activating fluid supply (20) and a carbon dioxide gas supply (30). The beverage precursor liquid supply (10) provides a precursor liquid (2). The cartridge chamber (3) is arranged to hold a cartridge (4). The cartridge (4) comprises an internal space which contains a carbon dioxide source (41) being is solid form having adsorbed carbon dioxide. The carbon dioxide source (41) emits carbon dioxide gas which carbonates the precursor liquid (2). The carbon dioxide activating fluid supply (20) provides fluids to the cartridge chamber (3) for contact with the carbon dioxide source (41) causing the source (41) to emit carbon dioxide gas. The carbon dioxide activating fluid supply (20) also controls an amount of fluid provided to the cartridge chamber (3) in order to control an amount of carbon dioxide gas emitted by the carbon dioxide source (41). The carbon dioxide gas supply (30) conducts carbon dioxide gas emitted by the carbon dioxide source (41) to the precursor liquid (2) via the beverage precursor liquid supply (10) to carbonate the precursor liquid (2) under a pressure greater than ambient pressure.
Patent NZ-608737-A (NZ)
Title: Fungicidal compositions and methods of use
Inventor: RIGGS JENNIFER
IPC: A01N43/16
Filed: 2011-08-09
Abstract: Provided are fungicidal compositions comprising a compound that produces systemic acquired resistance in plants or seeds, such as a saponin, and a fungicide, such as benalaxyl, furalaxyl, mefenoxam, metalaxyl or L-metalaxyl. Further provided is a method of protecting seeds or plants from disease by applying the fungicidal compositions, and additionally seeds comprising the fungicidal compositions.
Patent NZ-611782-A (NZ)
Title: Building jacking system and method
Inventor: KUO JIA
IPC: A23F3/16
Filed: 2013-01-18
Abstract: 611782 Disclosed is a beverage that includes beer and theophylline, wherein the theophylline is
Patent NZ-613242-A (NZ)
Title: Fabric clamping assembly
Inventor: SPENCER WONG
IPC: F16B5/06
Filed: 2013-07-15
Abstract: An upholstery or fabric covering (2) clamping assembly is disclosed. The assembly includes a plurality of insert clips (3) and a profiled member (1). The clips are inserted into the profiled member, securing and fastening the fabric in place. To accommodate different thicknesses or layers of fabric the point of clamping (5) by the clips inside the profiled member can be changed. The profiled member may be incorporated into a planar substrate or a frame.
Patent NZ-615443-A (NZ)
Title: Ecologically efficient vacuuming device
Inventor: SCHULTINK JAN
IPC: B01D46/04
Filed: 2012-03-21
Abstract: A suction or vacuum cleaner with a motor fan and a ribbed filter bag chamber or compartment is described. The ribs (62) keep the walls of a filter bag (65) from touching the sides of the filter chamber (65), thus increasing the efficiency, measured in accordance with quality factor formulae which use filtration efficiency and suction power parameters. The bag or pouch may also include surface pleats, which also increase efficiency or effectiveness of the bag.
Patent NZ-615621-A (NZ)
Title: Thieno [2,3-d] pyrimidine derivatives and their use to treat arrhythmia
Inventor: JOHN DEREK EDWARD
IPC: A61K31/519
Filed: 2012-03-29
Abstract: Disclosed is the compound 1-{ 5-Phenyl-4-[(pyridin-2-ylmethyl)-amino]-thieno[2,3-d]pyrimidin-2-yl} -piperidine-3-carboxylic acid (2-hydroxy-ethyl)-amide and enantiomers thereof. Also disclosed are pharmaceutical compositions comprising the compounds and their use as potassium channel inhibitors in the treatment of arrhythmia.
Patent NZ-626274-A (NZ)
Title: Laser cutting system and methods for creating self-retaining sutures
Inventor: NAIMAGON ALEXANDER
IPC: D02J3/10
Filed: 2011-05-04
Abstract: A laser-machining system and method is disclosed for forming retainers (130) on a suture thread (120). The laser system is preferably a femtosecond laser system which is capable of creating submicron features on the suture thread while preserving strength of the suture thread. The laser-machining system enables creation of retainers and self-retaining suture systems in configurations which are difficult and/or impossible to achieve using mechanical cutting technology. One method for making a self-retaining suture has the steps of (a) providing a suture thread having a surface; (b) identifying a first volume of suture material on the surface of the thread; (c) identifying a second volume of suture material from within the first volume of suture material; (d) directing a laser beam at the suture thread to ablate all of the suture material within the first volume of suture material with the exception of the second volume of suture material whereby the second volume of suture material forms a tissue retainer protruding from laser cut surface of the suture thread; and (e) repeating steps (b), (c) and (d) to generate a plurality of tissue retainers protruding from the suture thread.
Patent NZ-627585-A (NZ)
Title: Head protection systems, accessories, communications and/or control systems
Inventor: BLYTHE REES-JONES
IPC: H04W84/18
Filed: 2013-07-19
Abstract: A head protection system is disclosed. The system includes a protective shell (1) with a bottom rim and a harness (20) attached at a plurality of harness attachment points spaced above the bottom rim on an inside wall of the protective shell. The harness including a chin strap (21) configured, in use, to pass under a user’s chin to secure the protective shell to the user’s head. The shell has a plurality of first accessory attachment points (31) on its inside wall, the first accessory attachment points being positioned closer to the bottom rim than the harness attachment points. A plurality of headwear accessories (9), each including a plurality of second accessory attachment points on an outer surface thereof can be attached to the plurality of first accessory attachment points. In some embodiments the helmet includes sensors and a transceiver able to communicate to a hub. The hub may communicate to other sensors as part of a farm network. The helmet may also have a sensor to communicate where it is being worn currently to immobilise a vehicle if it is not.
Patent NZ-701495-A (NZ)
Title: Compositions comprising a biological control agent and an insecticide
Inventor: ANDERSCH WOLFRAM
IPC: A01P7/04
Filed: 2013-05-29
Abstract: The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of Bacillus chitinosporus AQ746 (NRRL Accession No. B-21 618), Bacillus mycoldes AQ726 (NRRL Accession No, B-21664), Bacillus pumilus (NRRL Accession No, B-30087), Bacillus pumilus AQ717 (NRRL Accession No. B-21662), Bacillus sp. AQ175 (ATCC Accession No. 55608), Bacillus sp. AQ177 (ATCC Accession No. 55609), Bacillus sp. AQ178 (ATCC Accession No. 53522), Bacillus subtilis AQ743 (NRRL Accession No, B-21 665), Bacillus subtilis AQ713 (NRRL Accession No. B- 21661), Bacillus subtilis AQ153 (ATCC Accession No. 55614), Bacillus thuringiensis BD#32 (NRRL Accession No. B-21530), Bacillus thuringiensis AQ52 (NRRL Accession No. B- 21619), Muscodor albus 620 (NRRL Accession No, 30547), Muscodor roseus A3-5 (NRRL Accession No. 30548), Rhodococcus globerulus AQ719 (NRRL Accession No. B-21663), Streptomyces galbus (NRRL Accession No, 30232), Streptomyces sp. (NRRL Accession No. B-30145), Bacillus thuringiensis subspec. kurstaki BMP 123, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421), and Bacillus subtilis AQ 30004 (NRRL Accession No. B- 50455) and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one insecticide selected from the group consisting of inhibitors of acetyl CoA carboxylase in a synergistlcally effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
Patent NZ-705900-A (NZ)
Title: Method for phone authentication in e-business transactions and computer-readable recording medium having program for phone authentication in e-business transactions recorded thereon
Inventor: KIM GWI YEOL
IPC: G06Q20/42
Filed: 2013-05-13
Abstract: The present invention relates to a method for phone authentication in e-business transactions using a terminal for phone authentication, which provides a non-repudiation function through a link to a trusted third party, and to a computer-readable recording medium having a program recorded thereon for phone authentication used in e-business transactions using a terminal for phone authentication, which provides the non-repudiation function by means of the link to the trusted third party.
Patent NZ-718711-A (NZ)
Title: 1,2,4-oxadiazole derivatives as immunomodulators
Inventor: RAMACHANDRA MURALIDHARA
IPC: A61K31/433
Filed: 2014-09-05
Abstract: The present invention relates to 1,2,4-oxadiazole and 1,2,4-thiadiazole compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signaling pathway. The invention also refers to derivatives of the therapeutic agents. The invention also encompasses the use of the said therapeutic agents and 5 derivatives for treatment of disorders via immunopotentiation comprising inhibition of immunosuppressive signal induced due to PD-1, PD-L1, or PD-L2 and therapies using them.
Patent NZ-722330-A (NZ)
Title: Reduced outflow inflation valve
Inventor: FOURNIE GLENN G
IPC: F16K27/02
Filed: 2014-11-18
Abstract: A reduced outflow valve in fluid communication with an inflatable apparatus comprising a tubular body defining an inner bore and a plunger slidingly engaged in the bore. The plunger defines an inner longitudinal bore that extends the length of the plunger, and has an elongated body, a flange at a first end of the body and at least one stop at a second end of the body. Inflation of the inflatable apparatus urges the plunger to a first position where the plunger is disposed within the bore and configured to allow rapid ingress of air into the inflatable apparatus to inflate the inflatable apparatus and deflation of the inflatable apparatus urges the plunger to a second position where the plunger is disposed within the bore and configured to dampen the egress of air from the inflatable apparatus.
Patent NZ-735755-A (NZ)
Title: Display system and method
Inventor: MILLER SAMUEL A
IPC: G06T19/00
Filed: 2014-03-14
Abstract: Disclosed is a method of operation in a virtual image presentation system. The method seeks to reduce instabilities of a virtual image that arise with rapid user movement due to system latency. The method comprises over-rendering a frame of a sequence of frames for a field of view provided by the virtual image presentation system such that a set of total pixels included in the frame exceeds a first set of pixels included in a reduced frame that is to be presented in a maximum area of display to a user when the display is configured to present one or more virtual images corresponding to the frame at a maximum image resolution. The method further comprises predicting, with a predictive head tracking module including one or more transducers in the virtual image presentation system, at least one predicted head movement of the user based at least in part upon a detected or predicted speed or a detected or predicted acceleration of head movement of the user. The method further comprises determining a smaller portion of the frame to present to the user based on at least one of a detected head movement and a predicted head movement, and selectively reading out the smaller portion of the frame from at least one frame buffer of the virtual image presentation system. Also disclosed is a virtual image presentation system.
Patent NZ-737001-A (NZ)
Title: Coin bin
Inventor: COSTA FERNANDO
IPC: G07F9/06
Filed: 2016-05-18
Abstract: The present invention provides a coin bin, comprising a body defining a chamber to receive coins, the body further defining a receiving area to releasably receive part of a steering handle and being formed of a structurally strong plastic; a lid to close the chamber, the lid being lockable and removable when unlocked; and a plurality of wheels affixed to the body to support the body. The coin bin is suitable for positioning inside an automatic teller machine (ATM). The steering handle imparts substantially better strength for lifting and stacking, allows substantially quicker attachment/detachment, and greatly enhances maneuverability. The coin bin also has recesses on the lid for the wheels of other coin bins, this prevents the bins from moving out of place when stacked during transport. It provides greater stability when the bins are stacked and give greater ease for the end user when maneuvering the stacked coin boxes.